- Home
- SNDX vs NGVC Comparison
SNDX vs NGVC Comparison
Compare SNDX & NGVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- NGVC
- Stock Information
- Founded
- SNDX 2005
- NGVC 1955
- Country
- SNDX United States
- NGVC United States
- Employees
- SNDX N/A
- NGVC N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- NGVC Food Chains
- Sector
- SNDX Health Care
- NGVC Consumer Staples
- Exchange
- SNDX Nasdaq
- NGVC Nasdaq
- Market Cap
- SNDX 974.9M
- NGVC 865.7M
- IPO Year
- SNDX 2016
- NGVC 2012
- Fundamental
- Price
- SNDX $11.54
- NGVC $47.76
- Analyst Decision
- SNDX Strong Buy
- NGVC
- Analyst Count
- SNDX 10
- NGVC 0
- Target Price
- SNDX $36.20
- NGVC N/A
- AVG Volume (30 Days)
- SNDX 1.9M
- NGVC 157.9K
- Earning Date
- SNDX 05-07-2025
- NGVC 05-08-2025
- Dividend Yield
- SNDX N/A
- NGVC 1.01%
- EPS Growth
- SNDX N/A
- NGVC 33.38
- EPS
- SNDX N/A
- NGVC 1.56
- Revenue
- SNDX $23,680,000.00
- NGVC $1,270,056,000.00
- Revenue This Year
- SNDX $286.51
- NGVC $1.32
- Revenue Next Year
- SNDX $120.86
- NGVC N/A
- P/E Ratio
- SNDX N/A
- NGVC $30.62
- Revenue Growth
- SNDX N/A
- NGVC 9.31
- 52 Week Low
- SNDX $9.66
- NGVC $15.82
- 52 Week High
- SNDX $25.07
- NGVC $50.91
- Technical
- Relative Strength Index (RSI)
- SNDX 44.37
- NGVC 69.30
- Support Level
- SNDX $9.66
- NGVC $45.81
- Resistance Level
- SNDX $11.61
- NGVC $48.12
- Average True Range (ATR)
- SNDX 1.01
- NGVC 2.90
- MACD
- SNDX 0.02
- NGVC 0.78
- Stochastic Oscillator
- SNDX 56.12
- NGVC 96.99
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
About NGVC Natural Grocers by Vitamin Cottage Inc.
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business are conducted. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.